A carregar...
Dapagliflozin for the treatment of type 2 diabetes: a review of the literature
OBJECTIVE: Dapagliflozin was the first drug in a class of therapies that took a new approach to glycemic control in adults with type 2 diabetes (T2D). It is an inhibitor of the sodium glucose cotransporter, resident in the proximal nephron, which is responsible for the recovery of filtered glucose b...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4267514/ https://ncbi.nlm.nih.gov/pubmed/25525338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S50963 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|